Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 28:9:1179299X17728254.
doi: 10.1177/1179299X17728254. eCollection 2017.

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer

Affiliations

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer

Charlotte Es Hoogstins et al. Biomark Cancer. .

Abstract

Peritoneal metastasis (PM) occurs in about 10% of patients with colorectal cancer (CRC). Fluorescence imaging can enhance contrast between cancerous and benign tissue, enabling the surgeon to clearly visualize PM during cytoreductive surgery. This study assessed the suitability of different biomarkers as potential targets for tumor-targeted imaging of PM of CRC. Tissue samples from primary tumor and PM from patients with CRC were obtained from the pathology archives and immunohistochemical stainings were performed. Overexpression of the epithelial cell adhesion molecule (EpCAM) and carcinoembryonic antigen (CEA) was seen in 100% of PM samples and the expression was strong in >70% of samples. Tyrosine-kinase Met (C-Met) and folate receptor α overexpression was seen in 20% of PM samples. For successful application of tumor-targeted intraoperative fluorescence imaging of PM, biomarkers need to be identified. We demonstrated that both EpCAM and CEA are suitable targets for fluorescence imaging of PM in patients with CRC.

Keywords: Image-guided surgery; biomarkers; colorectal cancer; fluorescence; metastasis; peritoneal metastasis.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Representative epithelial and stromal staining intensities in peritoneal metastasis from colorectal cancer using immunohistochemistry (as specified in the Methods section) at zoom 10x after immunohistochemistry. Examples of (A) strong 3+ epithelial staining intensity (CEA), (B) moderate 2+ epithelial staining intensity (C-Met), (C) weak 1+ epithelial staining intensity (C-Met), (D) absent 0 epithelial staining (FRα), (E) absent 0 stromal staining (EpCAM), (F) weak 1+ stromal staining (C-Met), and (G) moderate 2+ stromal staining (CEA). CEA indicates carcinoembryonic antigen; FRα, folate receptor α.

References

    1. Thomassen I, Van Gestel YR, Lemmens VE, De Hingh IH. Incidence, prognosis, and treatment options for patients with synchronous peritoneal metastasis and liver metastases from colorectal origin. Dis Colon Rectum. 2013;56:1373–1380. - PubMed
    1. Sugarbaker PH, Zhu BW, Sese GB, Shmookler B. Peritoneal metastasis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum. 1993;36:323–329. - PubMed
    1. Esquivel J, Chua TC. CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal metastasis: importance of the difference between statistical significance and clinical relevance. Ann Surg Oncol. 2009;16:2662–2663; author reply 2264. - PubMed
    1. Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal metastasis. Ann Surg Oncol. 2009;16:327–333. - PubMed
    1. Verwaal VJ, Van Ruth S, De Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal metastasis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743. - PubMed

LinkOut - more resources